Wockhardt Limited (NSE:WOCKPHARMA)
India
· Delayed Price · Currency is INR 1,316.55
-68.60 (-4.95%)
Feb 21, 2025, 3:29 PM IST
Wockhardt Employees
Wockhardt had 2,386 employees as of March 31, 2024. The number of employees decreased by 354 or -12.92% compared to the previous year.
Employees
2,386
Change (1Y)
-354
Growth (1Y)
-12.92%
Revenue / Employee
12.58M INR
Profits / Employee
-800.50K INR
Market Cap
213.90B
Employees Chart
Employees History
Related Stocks
| Company Name | Employees |
|---|---|
| Sun Pharmaceutical Industries | 43,000 |
| Divi's Laboratories | 9,741 |
| Cipla | 27,764 |
| Mankind Pharma | 19,540 |
| Apollo Hospitals Enterprise | 83,147 |
| Zydus Lifesciences | 26,921 |
| Aurobindo Pharma | 26,015 |
| Alkem Laboratories | 17,432 |
Wockhardt News
- 16 days ago - Wockhardt reports Q3 Results: Revenue up 3% to Rs 721 crore, Net profit at Rs 20 crore vs loss of Rs 86 crore YoY - Business Upturn
- 23 days ago - Wockhardt shares surge 10% as flagship antibiotic Zaynich demonstrates breakthrough clinical success - Business Upturn
- 23 days ago - Wockhardt’s Zaynich achieves 96.8% clinical cure rate, sets new benchmark in Phase III global study - Business Upturn
- 5 weeks ago - Wockhardt’s Zaynich achieves 97% efficacy in treating resistant infections - Business Upturn
- 7 weeks ago - Wockhardt shares surge nearly 5% after CDSCO approval for revolutionary antibiotic Miqnaf - Business Upturn
- 7 weeks ago - Stocks in Focus Today on January 4, 2025: Wockhardt, NHPC, RITES, IRFC, Hind Zinc and more - Business Upturn
- 7 weeks ago - Wockhardt launches new-generation oral antibiotic Miqnaf for community-acquired bacterial pneumonia (CABP) - Business Upturn
- 2 months ago - Wockhardt shares surge over 4% on successful Zaynich treatment for drug-resistant infections - Business Upturn